(Q37862425)

24 August 2017

1 reference

title

Infectious agents in human cancers: Lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV (English)

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

29 November 2024

2

David J. Blackbourn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21470769

29 November 2024

Graham S. Taylor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21470769

29 November 2024

language of work or name

English

0 references

publication date

5 April 2011

1 reference

full work available at URL

24 August 2017

https://api.elsevier.com/content/article/PII:S0304383511001595?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

https://api.elsevier.com/content/article/PII:S0304383511001595?httpAccept=text/plain

29 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

29 November 2024

1 reference

24 August 2017

volume

305

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

263-278

1 reference

Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture

24 August 2017

cites work

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NM0396-342

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NM0896-925

Characterization of two divergent lineages of macaque rhadinoviruses related to Kaposi's sarcoma-associated herpesvirus

1

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates?

29 November 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

29 November 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.

29 November 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

29 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy

29 November 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.

29 November 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link

29 November 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease

29 November 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Epstein-Barr virus: 40 years on

29 November 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The global health burden of infection-associated cancers in the year 2002

29 November 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Cloning the differences between two complex genomes

29 November 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

29 November 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)

29 November 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus immune modulation: an overview

29 November 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Human Herpesvirus 8 Detection in Nasal Secretions and Saliva

29 November 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Mucosal shedding of human herpesvirus 8 in men.

29 November 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients

29 November 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Human herpesvirus 8 in semen and prostate

29 November 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Increased human herpesvirus 8 seroprevalence in young homosexual men who have multiple sex contacts with different partners.

29 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia.

29 November 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission

29 November 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

29 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects

29 November 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

A review of human carcinogens--Part B: biological agents

29 November 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells

29 November 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Risk factors in the development of Kaposi's sarcoma

29 November 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy

29 November 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Herpes-Type Virus Particles in Tissue Culture of Kaposi's Sarcoma From Different Geographic Regions2

29 November 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation

29 November 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

29 November 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The enigmas of Kaposi's sarcoma

29 November 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance

29 November 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.

29 November 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Human herpesvirus 8 encodes a homolog of interleukin-6.

29 November 2024

39

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6.

29 November 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays

29 November 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus).

29 November 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma

29 November 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors

29 November 2024

46

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma

29 November 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells

29 November 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group

29 November 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Characterization of in vitro culture of HIV-negative Kaposi's sarcoma-derived cells. In vitro responses to alfa interferon

29 November 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro.

29 November 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.

29 November 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.

29 November 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells.

29 November 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals

29 November 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Isolation and Characterization of an Immortal Neoplastic Cell Line (KS Y-1) From AIDS-Associated Kaposi's Sarcoma

29 November 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Absence of human herpesvirus 8 DNA sequences in neoplastic Kaposi's sarcoma cell lines

29 November 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus

29 November 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures

29 November 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo

29 November 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

29 November 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway

29 November 2024

65

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus

29 November 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Cellular and molecular features of HIV-associated Kaposi's sarcoma

29 November 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection

29 November 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.

29 November 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus

29 November 2024

71

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation

29 November 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas

29 November 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases

29 November 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile

29 November 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Body-Cavity–Based Lymphoma in an HIV-Seronegative Patient without Kaposi's Sarcoma–Associated Herpesvirus-Like DNA Sequences

29 November 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

HIV-associated lymphomas and gamma-herpesviruses.

29 November 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Fifty years of multicentric Castleman's disease

29 November 2024

80

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease.

29 November 2024

82

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line

29 November 2024

84

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus.

29 November 2024

85

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53

29 November 2024

86

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Heterogeneity of viral IL-6 expression in HHV-8-associated diseases

29 November 2024

88

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus

29 November 2024

89

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

29 November 2024

90

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes.

29 November 2024

91

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Role of virus-encoded microRNAs in herpesvirus biology

29 November 2024

92

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Tandem array-based expression screens identify host mRNA targets of virus-encoded microRNAs

29 November 2024

93

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

A viral microRNA functions as an orthologue of cellular miR-155

29 November 2024

94

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155

29 November 2024

95

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

29 November 2024

96

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1.

29 November 2024

97

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses

29 November 2024

98

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1.

29 November 2024

99

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells

29 November 2024

101

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients.

29 November 2024

102

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Decreased EBNA-1-specific CD8+ T cells in patients with Epstein-Barr virus-associated nasopharyngeal carcinoma

29 November 2024

103

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Patients with Epstein Barr virus-positive lymphomas have decreased CD4(+) T-cell responses to the viral nuclear antigen 1.

29 November 2024

104

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Children with endemic Burkitt lymphoma are deficient in EBNA1-specific IFN-gamma T cell responses

29 November 2024

105

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

EBV-induced human CD8+ NKT cells suppress tumorigenesis by EBV-associated malignancies.

29 November 2024

106

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Peripheral gamma delta T-cell deficit in nasopharyngeal carcinoma

29 November 2024

107

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Phenotypic and functional alterations of Vgamma2Vdelta2 T cell subsets in patients with active nasopharyngeal carcinoma.

29 November 2024

108

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Identification of human herpesvirus 8-specific cytotoxic T-cell responses.

29 November 2024

109

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Definition of an optimal cytotoxic T lymphocyte epitope in the latently expressed Kaposi's sarcoma-associated herpesvirus kaposin protein

29 November 2024

110

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Lytic and latent antigens of the human gammaherpesviruses Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes

29 November 2024

111

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The CD8 and CD4 T-cell response against Kaposi's sarcoma-associated herpesvirus is skewed towards early and late lytic antigens.

29 November 2024

112

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia

29 November 2024

113

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.

29 November 2024

114

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma

29 November 2024

115

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

29 November 2024

116

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma

29 November 2024

117

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Prognostic Value of Quantitative Kaposi Sarcoma–Associated Herpesvirus Load in Posttransplantation Kaposi Sarcoma

29 November 2024

118

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda

29 November 2024

119

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda

29 November 2024

120

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma in organ transplant recipients: report of 20 cases

29 November 2024

121

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma

29 November 2024

122

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Potential role of natural killer cells in controlling growth and infiltration of AIDS-associated primary effusion lymphoma cells

29 November 2024

123

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes

29 November 2024

124

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Gamma delta+ T cells involvement in viral immune control of chronic human herpesvirus 8 infection

29 November 2024

125

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Bone marrow failure associated with human herpesvirus 8 infection after transplantation

29 November 2024

126

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load

29 November 2024

127

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

AIDS-associated Kaposiʼs sarcoma associated with a low viral load and a high CD4 cell count

29 November 2024

128

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposiʼs sarcoma in HIV-negative men having sex with men

29 November 2024

129

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma.

29 November 2024

130

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma

29 November 2024

131

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Association of immunoescape mechanisms with Epstein-Barr virus infection in nasopharyngeal carcinoma

29 November 2024

132

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death

29 November 2024

133

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Abundant expression of transforming growth factor-β1 and -β2 by Hodgkin's reed-sternberg cells and by reactive T lymphocytes in Hodgkin's disease

29 November 2024

134

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.

29 November 2024

136

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.

29 November 2024

137

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma

29 November 2024

138

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Increase in circulating Foxp3+CD4+CD25(high) regulatory T cells in nasopharyngeal carcinoma patients

29 November 2024

139

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy

29 November 2024

140

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells

29 November 2024

141

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Direct immunosuppressive effects of EBV-encoded latent membrane protein 1.

29 November 2024

142

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Localization of the Epstein-Barr virus protein LMP 1 to exosomes

29 November 2024

143

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Inflammatory cytokines inhibit Kaposi's sarcoma-associated herpesvirus lytic gene transcription in in vitro-infected endothelial cells

29 November 2024

144

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8

29 November 2024

146

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma

29 November 2024

147

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

KSHV and Kaposi's Sarcoma: The End of the Beginning?

29 November 2024

148

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia?

29 November 2024

149

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6

29 November 2024

150

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1

29 November 2024

151

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications

29 November 2024

152

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia

29 November 2024

153

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium

29 November 2024

154

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts

29 November 2024

155

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The role of endothelial-to-mesenchymal transition in cancer progression

29 November 2024

156

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming

29 November 2024

157

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Cancer associated fibroblasts promote tumor growth and metastasis by modulating the tumor immune microenvironment in a 4T1 murine breast cancer model

29 November 2024

158

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes

29 November 2024

159

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Inhibition of neutrophil function by the Kaposi's sarcoma-associated herpesvirus vOX2 protein

29 November 2024

160

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The tumor microenvironment controls primary effusion lymphoma growth in vivo

29 November 2024

161

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Host Immunogenetics and Control of Human Herpesvirus–8 Infection

29 November 2024

166

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Associations of Classic Kaposi Sarcoma with Common Variants in Genes that Modulate Host Immunity

29 November 2024

167

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines

29 November 2024

168

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.

29 November 2024

171

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro

29 November 2024

172

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

EBNA-1: a protein pivotal to latent infection by Epstein-Barr virus

29 November 2024

173

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen

29 November 2024

174

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

29 November 2024

175

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1

29 November 2024

176

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.

29 November 2024

177

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes

29 November 2024

178

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition.

29 November 2024

179

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1

29 November 2024

180

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Impact of Kaposi Sarcoma–Associated Herpesvirus (KSHV) Burden and HIV Coinfection on the Detection of T Cell Responses to KSHV ORF73 and ORF65 Proteins

29 November 2024

181

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing

29 November 2024

182

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

In cis inhibition of antigen processing by the latency-associated nuclear antigen I of Kaposi sarcoma herpes virus

29 November 2024

183

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The nested open reading frame in the Epstein-Barr virus nuclear antigen-1 mRNA encodes a protein capable of inhibiting antigen presentation in cis.

29 November 2024

184

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Autophagy fights disease through cellular self-digestion

29 November 2024

185

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Nuclear membrane-derived autophagy, a novel process that participates in the presentation of endogenous viral antigens during HSV-1 infection

29 November 2024

186

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Endogenous MHC class II processing of a viral nuclear antigen after autophagy.

29 November 2024

187

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy

29 November 2024

188

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

A novel inhibitory mechanism of mitochondrion-dependent apoptosis by a herpesviral protein

29 November 2024

189

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy

29 November 2024

190

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display.

29 November 2024

191

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

CD4+ T-cell responses to Epstein-Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines

29 November 2024

192

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processing

29 November 2024

193

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Epstein-Barr virus nuclear antigen 1 evades direct immune recognition by CD4+ T helper cells

29 November 2024

194

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines

29 November 2024

195

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells

29 November 2024

198

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Epstein-Barr nuclear antigen 1-specific CD4(+) Th1 cells kill Burkitt's lymphoma cells

29 November 2024

199

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

EBV latent membrane proteins (LMPs) 1 and 2 as immunotherapeutic targets: LMP-specific CD4+ cytotoxic T cell recognition of EBV-transformed B cell lines.

29 November 2024

200

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells

29 November 2024

201

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Dual stimulation of Epstein-Barr Virus (EBV)-specific CD4+- and CD8+-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma

29 November 2024

202

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus

29 November 2024

203

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

The DNase of gammaherpesviruses impairs recognition by virus-specific CD8+ T cells through an additional host shutoff function

29 November 2024

204

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus

29 November 2024

205

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins

29 November 2024

206

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition

29 November 2024

207

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5.

29 November 2024

208

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells.

29 November 2024

209

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

No significant association between HLA antigens and classic kaposi sarcoma: Molecular analysis of 49 jewish patients

29 November 2024

210

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Amino acid residue at position 13 in HLA-DR beta chain plays a critical role in the development of Kaposi's sarcoma in AIDS patients

29 November 2024

211

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

HLA-B, -DRB1/3/4/5, and -DQB1 gene polymorphisms in human immunodeficiency virus-related Kaposi's sarcoma.

29 November 2024

212

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Influence of HLA alleles on shedding of Kaposi sarcoma-associated herpesvirus in saliva in an African population

29 November 2024

213

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

29 November 2024

214

1 reference

https://api.crossref.org/works/10.1016/J.CANLET.2010.08.019

29 November 2024

Identifiers

1 reference

24 August 2017

1 reference